Ocular Therapeutix (OCUL) Inventory (2014 - 2026)

Ocular Therapeutix's Inventory history runs 13 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• On a quarterly basis, Inventory rose 14.32% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was $3.7 million, a 14.32% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 17.24% from the prior year.
• Inventory improved to $3.7 million in Q1 2026 per OCUL's latest filing, from $3.6 million in the prior quarter.
• Across five years, Inventory topped out at $3.7 million in Q1 2026 and bottomed at $1.4 million in Q1 2022.
• The 5-year median for Inventory is $2.4 million (2024), against an average of $2.5 million.
• Across the five-year window, Inventory surged 66.86% in 2023 and climbed 6.56% in 2024, its largest moves.
• Year by year, Inventory stood at $2.0 million in 2022, then rose by 16.77% to $2.3 million in 2023, then soared by 31.89% to $3.0 million in 2024, then grew by 17.24% to $3.6 million in 2025, then advanced by 4.85% to $3.7 million in 2026.
• Per Business Quant, the three latest OCUL Inventory figures stand at $3.7 million (Q1 2026), $3.6 million (Q4 2025), and $3.5 million (Q3 2025).